Announced
Completed
Synopsis
The Carlyle Group completed a $250m investment in Pharmapacks, an e-commerce enablement platform. The investment values Pharmapacks at $1.1bn. "Pharmapacks is experiencing unprecedented growth with massive market support and highly attractive industry dynamics. We are thrilled that our partnership with Carlyle, a world-class investment firm with extensive connectivity, data and global resources, will provide us with an opportunity to take significant steps to enter the next phase of our growth plans," Andrew Vagenas, Pharmapacks Chief Executive Officer.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.